Peter Mathen

2PUBLICATIONS
0CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Sep 29, 2021
Bench to bedside radiosensitizer development strategy for newly diagnosed glioblastoma.

Charlotte Degorre, Philip Tofilon, Kevin Camphausen

|Jun 16, 2020
Radiosensitizers in the temozolomide era for newly diagnosed glioblastoma.

Peter Mathen, Lindsay Rowe, Megan Mackey

Pageof 1

Frequent Collaborators